clonazepam has been researched along with prednisolone in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (40.00) | 29.6817 |
2010's | 6 (40.00) | 24.3611 |
2020's | 2 (13.33) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Incorpora, G; Mollica, F; Pampiglione, G; Pavone, L | 1 |
Akasaka, N; Kamimura, T; Kanazawa, O; Tohyama, J; Uchiyama, M | 1 |
Atasoy, HT; Atasoy, N; Sumer, MM; Unal, A | 1 |
Itoyama, Y; Izumi, R; Nagata, M; Nakashima, I; Nishiyama, S; Omata, K; Suzuki, N | 1 |
Kumar, A; Verma, A | 1 |
Hitomi, T; Ikeda, A; Jingami, N; Matsumoto, R; Takahashi, R; Takahashi, Y; Tanioka, K; Tojima, M; Yamakado, H | 1 |
Hamada, H; Haraki, T; Kawamoto, M; Miyoshi, H; Nakamura, R; Yamaga, A; Yasuda, T | 1 |
Chen, S; Shen, D; Zhou, H | 1 |
Sugita, K; Tani, N; Yamamoto, O; Yoshida, A | 1 |
1 review(s) available for clonazepam and prednisolone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
14 other study(ies) available for clonazepam and prednisolone
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Infantile spasms syndrome in monozygotic twins. A 7-year follow-up.
Topics: Adrenocorticotropic Hormone; Child; Child, Preschool; Clonazepam; Diseases in Twins; Drug Therapy, Combination; Follow-Up Studies; Humans; Infant; Prednisolone; Spasms, Infantile; Twins; Twins, Monozygotic | 1985 |
[Serial MEG change in a boy with Landau-Kleffner syndrome].
Topics: Anticonvulsants; Child; Clonazepam; Drug Therapy, Combination; Evoked Potentials, Auditory; Humans; Landau-Kleffner Syndrome; Magnetoencephalography; Male; Methylprednisolone; Predictive Value of Tests; Prednisolone; Pulse Therapy, Drug; Treatment Outcome; Valproic Acid | 2004 |
Treatment of idiopathic opsoclonus-myoclonus syndrome with intravenous immunoglobulin.
Topics: Adult; Anti-Inflammatory Agents; Anticonvulsants; Clonazepam; Female; Humans; Immunoglobulins, Intravenous; Paraneoplastic Syndromes, Nervous System; Prednisolone | 2004 |
[Case of multiple sclerosis with "yes-yes" type head tremor].
Topics: Adult; Anticonvulsants; Cervical Vertebrae; Clonazepam; Female; Head; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Prednisolone; Pulse Therapy, Drug; Spinal Cord; Treatment Outcome; Tremor | 2011 |
Neurocysticercosis presenting as acute psychosis: a rare case report from rural India.
Topics: Acetazolamide; Adult; Antipsychotic Agents; Benzodiazepines; Brain; Clonazepam; Glucocorticoids; Humans; India; Magnetic Resonance Imaging; Male; Neurocysticercosis; Olanzapine; Prednisolone; Treatment Outcome | 2013 |
[Two cases of acute onset of focal cortical reflex myoclonus following acute aseptic meningoencephalitis with positive anti-glutamate receptor autoantibody].
Topics: Acute Disease; Adult; Autoantibodies; Autoimmunity; Biomarkers; Clonazepam; Drug Therapy, Combination; Humans; Male; Meningoencephalitis; Methylprednisolone; Myoclonus; Prednisolone; Pulse Therapy, Drug; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2014 |
Transient symptomatic worsening by atropine in opsoclonus-myoclonus syndrome.
Topics: Adjuvants, Anesthesia; Anticonvulsants; Atropine; Child, Preschool; Clonazepam; Deep Sedation; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Infant; Magnetic Resonance Imaging; Opsoclonus-Myoclonus Syndrome; Prednisolone; Retrospective Studies; Tomography, X-Ray Computed | 2017 |
Spasms and Myoclonus in a Young Woman With Hashimoto Thyroiditis.
Topics: Adult; Anticonvulsants; Clonazepam; Diazepam; Encephalomyelitis; Female; Hashimoto Disease; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Muscle Rigidity; Myoclonus; Prednisolone; Spasm | 2020 |
Correlation between serum thymus and activation-regulated chemokine levels and eczematous drug eruption following oral challenge test with clonazepam.
Topics: Administration, Oral; Aged; Anticonvulsants; Benzimidazoles; Biopsy; Chemokine CCL17; Clonazepam; Drug Eruptions; Eosinophils; Glucocorticoids; Humans; Male; Oxadiazoles; Prednisolone; Skin; Treatment Outcome; Withholding Treatment | 2020 |